Medically reviewed by Suzanne Fisher, RDHypoglycemia (low blood sugar) treatments will depend on the severity of symptoms and ...

Gvoke VialDx has the potential to modernize the handling and administration of glucagon for diagnostic ... in adult patients were nausea, vomiting, injection site edema raised 1 mm or greater ...

Opko Health and Entera Bio have formalized their partnership as the biotechs prepare to take the first orally administered dual agonist glucagonlike-peptide 1 (GLP-1)/glucagon peptide into the clinic.

and GLP-1 (glucagon-like peptide-1) hormone receptors which eventually help with obesity, overweight and type 2 diabetes. According to the company, the injection is supposed to be taken once every ...